Tumor cell vaccination and IL-2 therapy

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.

International journal of oncology·2001

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.

Gene therapy·1999

Immunization with virus-modified tumor cells.

Seminars in oncology·1998

Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.

International journal of cancer·1998

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·1996

A monoclonal antibody specific for Pseudomonas aeruginosa amidase.

Hybridoma·2001

Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in E. coli.

Hybridoma·2001

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

Hybridoma·2001

Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application.

Hybridoma·2001

Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.

Hybridoma·2001

Production, characterization, and epitope mapping of monoclonal antibodies against human polydeoxyribonucleotide kinase.

Hybridoma·2001

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Frontiers in bioinformatics·2026

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Frontiers in allergy·2026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Crohn's & colitis 360·2026

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Frontiers in cell and developmental biology·2026

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Frontiers in immunology·2026

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Frontiers in immunology·2026

Related Experiment Videos

Tumor cell vaccination and IL-2 therapy

Related Concept Videos

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.

Immunization with virus-modified tumor cells.

Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

A monoclonal antibody specific for Pseudomonas aeruginosa amidase.

Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in E. coli.

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application.

Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.

Production, characterization, and epitope mapping of monoclonal antibodies against human polydeoxyribonucleotide kinase.

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Related Experiment Videos

Tumor cell vaccination and IL-2 therapy

Related Concept Videos

Related Articles